Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC326082 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9744 | High Similarity | NPC326529 |
0.9682 | High Similarity | NPC319100 |
0.9682 | High Similarity | NPC324198 |
0.9079 | High Similarity | NPC161224 |
0.8903 | High Similarity | NPC174802 |
0.8882 | High Similarity | NPC121222 |
0.8839 | High Similarity | NPC212551 |
0.8839 | High Similarity | NPC302778 |
0.8839 | High Similarity | NPC164952 |
0.8839 | High Similarity | NPC130586 |
0.879 | High Similarity | NPC226245 |
0.875 | High Similarity | NPC323091 |
0.8726 | High Similarity | NPC224076 |
0.871 | High Similarity | NPC85689 |
0.871 | High Similarity | NPC185991 |
0.871 | High Similarity | NPC211025 |
0.8654 | High Similarity | NPC321814 |
0.8553 | High Similarity | NPC316618 |
0.8421 | Intermediate Similarity | NPC209525 |
0.8421 | Intermediate Similarity | NPC161659 |
0.8323 | Intermediate Similarity | NPC107374 |
0.8323 | Intermediate Similarity | NPC21448 |
0.8323 | Intermediate Similarity | NPC156461 |
0.8312 | Intermediate Similarity | NPC314152 |
0.8269 | Intermediate Similarity | NPC189068 |
0.8269 | Intermediate Similarity | NPC164665 |
0.8217 | Intermediate Similarity | NPC309832 |
0.8217 | Intermediate Similarity | NPC269827 |
0.8217 | Intermediate Similarity | NPC219313 |
0.8194 | Intermediate Similarity | NPC229974 |
0.8176 | Intermediate Similarity | NPC189261 |
0.8065 | Intermediate Similarity | NPC317821 |
0.8036 | Intermediate Similarity | NPC324033 |
0.8036 | Intermediate Similarity | NPC321458 |
0.7976 | Intermediate Similarity | NPC261595 |
0.7963 | Intermediate Similarity | NPC472816 |
0.7904 | Intermediate Similarity | NPC14590 |
0.7879 | Intermediate Similarity | NPC239737 |
0.7744 | Intermediate Similarity | NPC207633 |
0.7669 | Intermediate Similarity | NPC136349 |
0.7658 | Intermediate Similarity | NPC129756 |
0.7636 | Intermediate Similarity | NPC328479 |
0.7622 | Intermediate Similarity | NPC150853 |
0.7619 | Intermediate Similarity | NPC195140 |
0.7605 | Intermediate Similarity | NPC52238 |
0.7595 | Intermediate Similarity | NPC33996 |
0.756 | Intermediate Similarity | NPC313754 |
0.756 | Intermediate Similarity | NPC311197 |
0.756 | Intermediate Similarity | NPC54320 |
0.7531 | Intermediate Similarity | NPC317746 |
0.7485 | Intermediate Similarity | NPC232408 |
0.7485 | Intermediate Similarity | NPC64705 |
0.7484 | Intermediate Similarity | NPC30326 |
0.7469 | Intermediate Similarity | NPC318590 |
0.7423 | Intermediate Similarity | NPC89147 |
0.7423 | Intermediate Similarity | NPC274384 |
0.7423 | Intermediate Similarity | NPC177169 |
0.7362 | Intermediate Similarity | NPC251233 |
0.7362 | Intermediate Similarity | NPC211820 |
0.7358 | Intermediate Similarity | NPC320818 |
0.7346 | Intermediate Similarity | NPC186619 |
0.7299 | Intermediate Similarity | NPC324484 |
0.7273 | Intermediate Similarity | NPC290959 |
0.7257 | Intermediate Similarity | NPC325906 |
0.7207 | Intermediate Similarity | NPC313897 |
0.7202 | Intermediate Similarity | NPC326694 |
0.7151 | Intermediate Similarity | NPC93365 |
0.712 | Intermediate Similarity | NPC24589 |
0.7097 | Intermediate Similarity | NPC282458 |
0.7097 | Intermediate Similarity | NPC78941 |
0.7053 | Intermediate Similarity | NPC107160 |
0.6975 | Remote Similarity | NPC262926 |
0.6952 | Remote Similarity | NPC21461 |
0.6933 | Remote Similarity | NPC61198 |
0.6825 | Remote Similarity | NPC313514 |
0.6821 | Remote Similarity | NPC321052 |
0.6748 | Remote Similarity | NPC324009 |
0.6707 | Remote Similarity | NPC319221 |
0.6686 | Remote Similarity | NPC315642 |
0.6686 | Remote Similarity | NPC74306 |
0.6667 | Remote Similarity | NPC276373 |
0.6633 | Remote Similarity | NPC5802 |
0.66 | Remote Similarity | NPC157821 |
0.6544 | Remote Similarity | NPC158055 |
0.6413 | Remote Similarity | NPC33382 |
0.6378 | Remote Similarity | NPC168702 |
0.6378 | Remote Similarity | NPC125659 |
0.631 | Remote Similarity | NPC222174 |
0.6244 | Remote Similarity | NPC250178 |
0.6196 | Remote Similarity | NPC321393 |
0.6154 | Remote Similarity | NPC57279 |
0.6131 | Remote Similarity | NPC104011 |
0.6131 | Remote Similarity | NPC246193 |
0.6111 | Remote Similarity | NPC327579 |
0.6104 | Remote Similarity | NPC476564 |
0.6013 | Remote Similarity | NPC87981 |
0.6013 | Remote Similarity | NPC174114 |
0.6011 | Remote Similarity | NPC472834 |
0.5964 | Remote Similarity | NPC160666 |
0.5912 | Remote Similarity | NPC4837 |
0.5912 | Remote Similarity | NPC312187 |
0.5833 | Remote Similarity | NPC248007 |
0.581 | Remote Similarity | NPC103388 |
0.5722 | Remote Similarity | NPC217656 |
0.5696 | Remote Similarity | NPC18335 |
0.5691 | Remote Similarity | NPC89139 |
0.5685 | Remote Similarity | NPC164845 |
0.5674 | Remote Similarity | NPC296437 |
0.5665 | Remote Similarity | NPC287876 |
0.5655 | Remote Similarity | NPC139776 |
0.5642 | Remote Similarity | NPC470266 |
0.5607 | Remote Similarity | NPC14330 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC326082 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9682 | High Similarity | NPD4171 | Clinical (unspecified phase) |
0.8903 | High Similarity | NPD339 | Approved |
0.8839 | High Similarity | NPD338 | Approved |
0.8726 | High Similarity | NPD169 | Phase 2 |
0.871 | High Similarity | NPD283 | Approved |
0.8599 | High Similarity | NPD242 | Approved |
0.8415 | Intermediate Similarity | NPD7988 | Suspended |
0.8353 | Intermediate Similarity | NPD4716 | Approved |
0.8323 | Intermediate Similarity | NPD250 | Approved |
0.8323 | Intermediate Similarity | NPD249 | Approved |
0.8312 | Intermediate Similarity | NPD185 | Approved |
0.8304 | Intermediate Similarity | NPD4744 | Clinical (unspecified phase) |
0.825 | Intermediate Similarity | NPD1369 | Phase 2 |
0.8217 | Intermediate Similarity | NPD195 | Approved |
0.8217 | Intermediate Similarity | NPD186 | Discovery |
0.8205 | Intermediate Similarity | NPD166 | Approved |
0.8182 | Intermediate Similarity | NPD193 | Suspended |
0.8137 | Intermediate Similarity | NPD1750 | Clinical (unspecified phase) |
0.8137 | Intermediate Similarity | NPD3107 | Discontinued |
0.8121 | Intermediate Similarity | NPD3083 | Approved |
0.8098 | Intermediate Similarity | NPD2646 | Discontinued |
0.8098 | Intermediate Similarity | NPD2624 | Phase 2 |
0.8023 | Intermediate Similarity | NPD1412 | Clinical (unspecified phase) |
0.7988 | Intermediate Similarity | NPD1732 | Phase 3 |
0.7976 | Intermediate Similarity | NPD247 | Clinical (unspecified phase) |
0.7939 | Intermediate Similarity | NPD4074 | Clinical (unspecified phase) |
0.7809 | Intermediate Similarity | NPD6417 | Clinical (unspecified phase) |
0.773 | Intermediate Similarity | NPD3085 | Phase 1 |
0.7722 | Intermediate Similarity | NPD2632 | Approved |
0.7722 | Intermediate Similarity | NPD2631 | Clinical (unspecified phase) |
0.7722 | Intermediate Similarity | NPD2630 | Approved |
0.7719 | Intermediate Similarity | NPD2647 | Phase 3 |
0.7701 | Intermediate Similarity | NPD5666 | Phase 2 |
0.7683 | Intermediate Similarity | NPD3086 | Phase 3 |
0.7669 | Intermediate Similarity | NPD548 | Clinical (unspecified phase) |
0.7598 | Intermediate Similarity | NPD1692 | Approved |
0.756 | Intermediate Similarity | NPD219 | Phase 3 |
0.756 | Intermediate Similarity | NPD220 | Clinical (unspecified phase) |
0.756 | Intermediate Similarity | NPD218 | Approved |
0.756 | Intermediate Similarity | NPD216 | Approved |
0.756 | Intermediate Similarity | NPD217 | Approved |
0.7486 | Intermediate Similarity | NPD4054 | Clinical (unspecified phase) |
0.7485 | Intermediate Similarity | NPD213 | Clinical (unspecified phase) |
0.7485 | Intermediate Similarity | NPD214 | Approved |
0.7484 | Intermediate Similarity | NPD248 | Discontinued |
0.7423 | Intermediate Similarity | NPD7158 | Phase 1 |
0.7355 | Intermediate Similarity | NPD870 | Clinical (unspecified phase) |
0.7257 | Intermediate Similarity | NPD1776 | Approved |
0.7257 | Intermediate Similarity | NPD1777 | Approved |
0.7197 | Intermediate Similarity | NPD9633 | Phase 3 |
0.7151 | Intermediate Similarity | NPD546 | Clinical (unspecified phase) |
0.7135 | Intermediate Similarity | NPD5683 | Clinical (unspecified phase) |
0.7135 | Intermediate Similarity | NPD5684 | Clinical (unspecified phase) |
0.7135 | Intermediate Similarity | NPD5682 | Phase 3 |
0.7115 | Intermediate Similarity | NPD9408 | Phase 3 |
0.7073 | Intermediate Similarity | NPD3696 | Approved |
0.7073 | Intermediate Similarity | NPD3695 | Approved |
0.7044 | Intermediate Similarity | NPD9632 | Phase 3 |
0.6933 | Remote Similarity | NPD252 | Clinical (unspecified phase) |
0.6901 | Remote Similarity | NPD3708 | Phase 2 |
0.6836 | Remote Similarity | NPD516 | Clinical (unspecified phase) |
0.6825 | Remote Similarity | NPD7138 | Phase 2 |
0.678 | Remote Similarity | NPD5080 | Phase 2 |
0.6772 | Remote Similarity | NPD1063 | Phase 2 |
0.6768 | Remote Similarity | NPD194 | Clinical (unspecified phase) |
0.6766 | Remote Similarity | NPD549 | Approved |
0.6746 | Remote Similarity | NPD4240 | Approved |
0.6732 | Remote Similarity | NPD5079 | Phase 2 |
0.6706 | Remote Similarity | NPD171 | Discontinued |
0.6686 | Remote Similarity | NPD582 | Approved |
0.665 | Remote Similarity | NPD2965 | Clinical (unspecified phase) |
0.6629 | Remote Similarity | NPD536 | Clinical (unspecified phase) |
0.6617 | Remote Similarity | NPD2876 | Phase 3 |
0.6617 | Remote Similarity | NPD2877 | Clinical (unspecified phase) |
0.6552 | Remote Similarity | NPD2824 | Phase 2 |
0.6544 | Remote Similarity | NPD6840 | Approved |
0.6488 | Remote Similarity | NPD4495 | Phase 1 |
0.6477 | Remote Similarity | NPD353 | Discontinued |
0.6455 | Remote Similarity | NPD1046 | Clinical (unspecified phase) |
0.6425 | Remote Similarity | NPD2903 | Clinical (unspecified phase) |
0.6425 | Remote Similarity | NPD2902 | Phase 2 |
0.6348 | Remote Similarity | NPD231 | Clinical (unspecified phase) |
0.6171 | Remote Similarity | NPD7502 | Clinical (unspecified phase) |
0.6167 | Remote Similarity | NPD9605 | Phase 3 |
0.6163 | Remote Similarity | NPD799 | Phase 1 |
0.6149 | Remote Similarity | NPD9606 | Approved |
0.6111 | Remote Similarity | NPD9607 | Approved |
0.6102 | Remote Similarity | NPD1730 | Discontinued |
0.6082 | Remote Similarity | NPD1119 | Phase 2 |
0.6057 | Remote Similarity | NPD2253 | Discontinued |
0.6023 | Remote Similarity | NPD209 | Clinical (unspecified phase) |
0.6023 | Remote Similarity | NPD1058 | Discontinued |
0.6019 | Remote Similarity | NPD4459 | Clinical (unspecified phase) |
0.6019 | Remote Similarity | NPD4458 | Phase 2 |
0.6012 | Remote Similarity | NPD6112 | Approved |
0.5976 | Remote Similarity | NPD9409 | Discontinued |
0.5974 | Remote Similarity | NPD8250 | Phase 2 |
0.5957 | Remote Similarity | NPD527 | Clinical (unspecified phase) |
0.595 | Remote Similarity | NPD2152 | Clinical (unspecified phase) |
0.5904 | Remote Similarity | NPD2593 | Clinical (unspecified phase) |
0.5872 | Remote Similarity | NPD545 | Clinical (unspecified phase) |
0.5864 | Remote Similarity | NPD9374 | Approved |
0.5839 | Remote Similarity | NPD9373 | Approved |
0.5837 | Remote Similarity | NPD5486 | Discontinued |
0.5833 | Remote Similarity | NPD9084 | Phase 2 |
0.5818 | Remote Similarity | NPD307 | Approved |
0.5814 | Remote Similarity | NPD282 | Approved |
0.5801 | Remote Similarity | NPD7531 | Clinical (unspecified phase) |
0.5787 | Remote Similarity | NPD1431 | Approved |
0.5787 | Remote Similarity | NPD1430 | Approved |
0.578 | Remote Similarity | NPD547 | Clinical (unspecified phase) |
0.5769 | Remote Similarity | NPD775 | Approved |
0.5755 | Remote Similarity | NPD5458 | Discontinued |
0.5747 | Remote Similarity | NPD6381 | Phase 2 |
0.5744 | Remote Similarity | NPD4089 | Clinical (unspecified phase) |
0.5735 | Remote Similarity | NPD4715 | Clinical (unspecified phase) |
0.5735 | Remote Similarity | NPD4713 | Clinical (unspecified phase) |
0.5735 | Remote Similarity | NPD4714 | Approved |
0.5735 | Remote Similarity | NPD34 | Approved |
0.573 | Remote Similarity | NPD1118 | Discontinued |
0.5728 | Remote Similarity | NPD2452 | Phase 2 |
0.5728 | Remote Similarity | NPD2453 | Phase 2 |
0.5728 | Remote Similarity | NPD2450 | Phase 2 |
0.5728 | Remote Similarity | NPD2451 | Phase 2 |
0.5714 | Remote Similarity | NPD207 | Discontinued |
0.5696 | Remote Similarity | NPD8836 | Approved |
0.5667 | Remote Similarity | NPD4599 | Clinical (unspecified phase) |
0.5665 | Remote Similarity | NPD8829 | Clinical (unspecified phase) |
0.5657 | Remote Similarity | NPD9083 | Clinical (unspecified phase) |
0.564 | Remote Similarity | NPD1127 | Approved |
0.564 | Remote Similarity | NPD1128 | Approved |
0.5616 | Remote Similarity | NPD3913 | Clinical (unspecified phase) |
PubChem CID   | 11104208 |
ChEMBL   | CHEMBL3144372 |
ZINC   |
Molecular Weight:   | 644.13 |
ALogP:   | -3.3754 |
MLogP:   | 1.13 |
XLogP:   | -4.714 |
# Rotatable Bonds:   | 16 |
Polar Surface Area:   | 320.07 |
# H-Bond Aceptor:   | 21 |
# H-Bond Donor:   | 6 |
# Rings:   | 6 |
# Heavy Atoms:   | 43 |